Phase3 comparative confirmatory study of K-877 against fenofibrate
Latest Information Update: 13 Jun 2016
Price :
$35 *
At a glance
- Drugs Pemafibrate (Primary) ; Fenofibrate
- Indications Dyslipidaemias
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Kowa Pharmaceutical
- 13 Jun 2016 New trial record